Phenomenex
Kranthi Chebrolu is a highly skilled scientist with extensive experience in proteomics and bioanalysis. Currently serving as a Staff Scientist at Phenomenex, Kranthi specializes in oligonucleotide impurity separations and assay development. Previously, Kranthi held the position of Principal Scientist at Bristol Myers Squibb, making significant contributions to the characterization and bioanalysis of antibody-drug conjugates (ADCs) and small molecules during the discovery stage. Kranthi's role at SCIEX as Global Technical Marketing Manager involved leading bioanalytical experiments in metabolomics and generating technical marketing content for advanced mass spectrometry systems. A Postdoctoral Research Associate at the Donald Danforth Plant Science Center, Kranthi focused on biomarker discovery using high-resolution mass spectrometry. Kranthi also served as a Senior Research Associate at North Carolina State University, developing methods for bio-analysis in both non-clinical and clinical trials. Kranthi earned a Doctor of Philosophy in Biochemistry from Texas A&M University.
This person is not in any teams
This person is not in any offices
Phenomenex
1 followers
Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, government and academic laboratories. From drug discovery and pharmaceutical development to disease diagnosis, food safety to environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve global health and well-being. Phenomenex Inc. is proud to be a part of Danaher Corporation's Life Sciences group. Company Website: www.phenomenex.com Nerdy Science Blog - Science Unfiltered: www.phenomenex.blog